Revenue
$139.7M
▲ 120.0% YoY
Net Income
-$80.0M
▲ 78.8% YoY
EPS
$-0.81
▲ 82.3% YoY
Cash
$294.9M
▲ 4.6% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Evans John M. CEO | Sell | Apr 1, 2026 | 30.1K | $24.58 | $739K | Form 4 ↗ |
Simon Amy Chief Medical Officer | Sell | Apr 1, 2026 | 6.7K | $24.58 | $165K | Form 4 ↗ |
Cavanagh Bethany J SVP, Finance and Treasurer | Sell | Apr 1, 2026 | 3.2K | $24.58 | $80K | Form 4 ↗ |
Bellon Christine Chief Legal Officer | Sell | Apr 1, 2026 | 6.0K | $24.58 | $146K | Form 4 ↗ |
Ciaramella Giuseppe President | Sell | Apr 1, 2026 | 11.8K | $24.58 | $290K | Form 4 ↗ |
Bellon Christine Chief Legal Officer | Grant | Mar 31, 2026 | 20.0K | $0.00 | $0 | Form 4 ↗ |
Cavanagh Bethany J SVP, Finance and Treasurer | Grant | Mar 31, 2026 | 20.0K | $0.00 | $0 | Form 4 ↗ |
Simon Amy Chief Medical Officer | Grant | Mar 31, 2026 | 31.8K | $0.00 | $0 | Form 4 ↗ |
Emany Sravan Kumar Chief Financial Officer | Grant | Mar 31, 2026 | 31.8K | $0.00 | $0 | Form 4 ↗ |
Ciaramella Giuseppe President | Grant | Mar 31, 2026 | 40.0K | $0.00 | $0 | Form 4 ↗ |
Evans John M. CEO | Vest | Mar 31, 2026 | 25.0K | $0.67 | $17K | Form 4 ↗ |
Evans John M. CEO | Sell | Mar 31, 2026 | 25.0K | $22.76 | $569K | Form 4 ↗ |
Evans John M. CEO | Grant | Mar 31, 2026 | 90.0K | $0.00 | $0 | Form 4 ↗ |
Evans John M. CEO | Vest | Mar 30, 2026 | 25.0K | $0.67 | $17K | Form 4 ↗ |
Evans John M. CEO | Sell | Mar 30, 2026 | 25.0K | $22.37 | $559K | Form 4 ↗ |
Ciaramella Giuseppe President | Vest | Feb 24, 2026 | 35.0K | $17.00 | $595K | Form 4 ↗ |
Ciaramella Giuseppe President | Sell | Feb 24, 2026 | 35.0K | $32.00 | $1.12M | Form 4 ↗ |